scholarly journals Economic burden of cardiovascular diseases from 2012 to 2017 based on French national claim database

2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
M Nicolas ◽  
L Pestel ◽  
S Rivière ◽  
A Rachas ◽  
C Gastaldi-Menager
Keyword(s):  
Heart Disease ◽  
Cardiovascular Diseases ◽  
Economic Burden ◽  
General Scheme ◽  
Claim Database ◽  
Total Expenditure ◽  
Coronary Syndrome ◽  
Number Of Patients ◽  
Chronic Coronary Heart Disease ◽  
And Control

Abstract Background The purpose of this study was to assess the economic burden of cardiovascular diseases (CVDs) in France by analysing the structure and the growth of expenditure attributed to these diseases between 2012 and 2017. Methods For each year, 11 CVDs were identified from SNDS data using algorithms based on long-term disease registry and hospitalization diagnoses, applied to the population of national health insurance general scheme beneficiaries. The individuals’ expenditure (26 different items) reimbursed for hospitalisations, ambulatory care and cash payments were included. A top-down method was used to attribute expenditure to each considered groups of diseases based on the average expenditure by disease calculated for individuals with only one disease. To analyse trends, we applied the same methodology from 2012 to 2017. Results In 2017, of the €140.1 billion reimbursed, €14.0 billion (10.0%) were attributed to the care of 4.0 million people with a CVD (7.0% of the population). Short-stay hospitalisations accounted for 33% of this total expenditure. This proportion was higher for acute CVD (coronary syndrome: 64%, stroke: 56%, heart failure: 65%, pulmonary embolism: 69%) but also for valvular heart disease (50.0%). Medications represented almost 13% of the expenditure attributed to all CVDs, and up to 25% for chronic coronary heart disease. Disability pension essentially concerned sequelae of stroke (12% of the expenditure attributed to this disease). Between 2012 and 2017, the total expenditure attributed to CVDs increased by 3.3% per year, mainly due to the annual mean increase of the number of patients over the period (+3.1%). Conclusions These results demonstrate the high economic burden of CVDs in France with a detailed analysis of expenditures and their main drivers. The developed tool will help decision makers to monitor the burden of these diseases but also to provide stake holders with a better understanding of trends and regulating actions. Key messages Economic burden of CVD in France is high: 10% of healthcare expenditure. Implementation of public health policy to prevent CVD and control risk factors must be a priority.

scholarly journals Economic burden of diabetes in France between 2012 and 2017 based on French national claim database

2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
P Denis ◽  
A Aguadé ◽  
T Lesuffleur ◽  
L Pestel ◽  
M Nicolas ◽  
...  
Keyword(s):  
Process Control ◽  
Economic Burden ◽  
General Scheme ◽  
Health Care Expenditure ◽  
Ageing Process ◽  
Claim Database ◽  
Medical Visit ◽  
Top Down ◽  
Number Of Patients ◽  
A Priority

Abstract Background The aim of this study is to assess the economic burden of diabetes in France based on a top-down allocation of health care expenditure, and to analyze structure and trends of expenditure between 2012 and 2017. Methods Using information about 57 millions of individuals from the general scheme insurance database (87% of the French population), we applied algorithms based on ICD-10 diagnoses, long-term diseases, and specific treatments. All reimbursed expenditure (drugs, medical visit and other ambulatory care, hospitalization, disability/sickness benefits) were extracted for each individual. A top-down method was used to allocate expenditure to diabetes. To analyze trends, we applied the same methodology from 2012 through 2017. Results In 2016 (results for 2017 will be available for the conference), among the 137 billion euros reimbursed, 6.8 billion (5%) were attributed to diabetes and 3.2 million people were concerned (5.5% of the population). Drugs represented the main expenditure item (31% of the average annual expenditure per patient related to diabetes), followed by nursing (18%) and medical devices (17.5%). From 2012 to 2016, the number of people with diabetes increased by 11.4% (+322 700) with an increase by 2.7%/year, the expenditure attributed to diabetes increased by 2.3%/year. The average expenditure per patient in 2016 was about €2150, slightly decreasing from 2012, mainly due to price controls on antidiabetics drugs which permits to limit expenditure growth. Conclusions Our study shows the high economic burden of diabetes in France with a detailed analysis of expenditures and their main drivers. With the arrival of innovation and predicted increase of the number of patients partly related to ageing process, control of expenditure must be a priority. The developed tool will help decision makers to monitor the burden of diabetes but also to provide stakeholders with a better understanding of trends and regulating actions. Key messages Diabetes represents a high proportion of healthcare expenditure in France. With the arrival of innovation and predicted increase of the number of patients partly related to ageing process, control of expenditure must be a priority.

Study on Heart Failure Patients Admitted in National Institute of Cardiovascular Diseases

2021 ◽  
Vol 13 (2) ◽  
pp. 172-176
Author(s):  
Nur Alam ◽  
Abdullah Al Shafi Majumder
Keyword(s):  
Heart Failure ◽  
Acute Coronary Syndrome ◽  
Heart Disease ◽  
Cardiovascular Diseases ◽  
Epidemiological Studies ◽  
Clinical Syndrome ◽  
Cross Sectional ◽  
Common Cause ◽  
Heart Failure Patients ◽  
Coronary Syndrome

Background: Heart failure is a complex clinical syndrome that arises secondary to abnormalities of cardiac structure and/or function (inherited or acquired) that impair the ability of the left ventricle to fill or eject blood. There is a paucity of data on characteristics of the patients of heart failure admitted in hospitals in terms of demographic and etiological information. So, this study aimed to see the disease burden of heart failure patients and the age and sex specific prevalence of heart failure among patients admitted into NICVD and to identify the etiological pattern of diseases leading to heart failure with associated comorbid factors. Methods: It was a cross sectional study carried out at National Institute of Cardiovascular Diseases (NICVD) Dhaka Bangladesh and was conducted from January 2015 to December 2015. Total 400 heart failure patients were taken. Results: The mean age of the patients were 54 ± 14 years ranging from 16 to 95 years with a high preponderance of male. Most the patient population was in the age group of 51- 60 years (29.5%). 79% of the cases were male & 21% female by gender specification. Ischaemic cardiomyopathy (ICM) was found to be the common cause of heart failure (n=153, 40.75%) followed by Acute coronary syndrome (32.5%) and Valvular heart disease (18.25%). The patients with heart failure having acute coronary syndrome (n=107) had hypertension (46.8%) as the most prevalent major risk factor. In the present study only 11% patient had heart failure with preserved ejection fraction. Mortality rate of the study population were 6.3%. Conclusion: In this study, the most common cause of heart failure is ischaemic heart disease. So, patients of acute and chronic ischemic heart disease patients should be treated and follow up with care. Clinical and epidemiological studies are needed to explore further. Cardiovasc. j. 2021; 13(2): 172-176

scholarly journals Analysis of consequences of the relationship between man, nature and technology in the context of technogenesis intellectualization

2020 ◽  
Vol 222 ◽  
pp. 05008
Author(s):  
Galina Ulivanova ◽  
Olga Fedosova ◽  
Galina Glotova ◽  
Olga Antoshina ◽  
Alexandra Fetisova
Keyword(s):  
Heart Disease ◽  
Cardiovascular Diseases ◽  
Life Expectancy ◽  
Ischemic Heart Disease ◽  
Aged People ◽  
The Past ◽  
Number Of Patients ◽  
Working Age ◽  
Working Age Population ◽  
The Relationship

The paper presents the results of the analysis of demographic and medico-social data characterizing the dynamics of morbidity and mortality from environmental diseases, in particular, diseases of the cardiovascular system. The trend of negative natural population growth was revealed, amounting to -6.9 per 1,000 persons by 2019. The number of patients with cardiovascular diseases was 13 817,4 persons, with the overwhelming majority of the working-age population (9020,2 persons). Ischemic heart disease had the largest share in the structure of the studied diseases (62,25 %). There was also a decrease in life expectancy over the past 30 years and an increase in mortality of young and middle-aged people.

scholarly journals Economic burden of cancer from 2012 to 2017 based on the French national claim database (SNDS)

2019 ◽  
Vol 29 (Supplement_4) ◽  
Author(s):  
D Verboux ◽  
L Pestel ◽  
M Nicolas ◽  
T Lesuffleur ◽  
A Rachas ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Prostate Cancer ◽  
Ambulatory Care ◽  
Economic Burden ◽  
General Scheme ◽  
Significant Proportion ◽  
Claim Database ◽  
Average Annual Cost ◽  
Analyze Structure ◽  
Active Cancer

Abstract Background The aim of this study is to assess the economic burden of active cancer in France and to analyze structure and trends of expenditure between 2012 and 2017. Methods Using information about 57 millions of individuals from the general scheme insurance database (86% of the French population) and applying 5 specifically developed medical algorithms (for lung, colon, breast, prostate and other cancers), we identified all people with active cancer. All reimbursed expenditure (hospitalization, ambulatory care, disability/sickness benefits) were extracted for each individual. To analyze trends, we applied the same methodology from 2012 through 2017. Results In 2016 (results for 2017 will be available for the conference), among the 137 billion euros reimbursed by the general assurance scheme, 13 billion (10%) were related to active cancer and 1.2 million people were concerned (2% of the population). About 2.3 billion euros (2%) were related to breast cancer (189,000 people), 1.4 billion euros (1%) for colon cancer (123,000 people), 1.4 billion euros (1%) for lung cancer (77,000 people) and 1 billion (0.8%) for prostate cancer (167,000 people). Hospitalizations represented the main expenditure for colon (71%), lung (61%) and breast cancer (56%). Concerning prostate cancer, hospitalizations stood for 36% while ambulatory care represented 62%. From 2012 to 2016, the expenditure related to active cancer increase by 4.4%/year due to both an increase in patients and in the average annual cost per patient (both +2.2% per year). Focusing on breast cancer, average expenditure increased by 3.2% per year from 10,700€ per year per patient to 12,200€ per year per patient. Conclusions Our study demonstrates the high economic burden of active cancer in France with a detailed analysis of expenditures. The developed tool will help to monitor the burden of these diseases and to implement public health policies. Key messages Active cancers account for a significant proportion of healthcare expenditure in France. Knowing this weight allows designing and implementing public policies adapted to the situation.

Psychophysiological Rationale for Use of Yoga in Heart Disease

2018 ◽  
pp. 203-217
Author(s):  
Subhash Manchanda ◽  
Kushal Madan
Keyword(s):  
Developing Countries ◽  
Heart Disease ◽  
Cardiovascular Diseases ◽  
Secondary Prevention ◽  
Cause Of Death ◽  
Economic Burden ◽  
Cost Effective ◽  
Unhealthy Lifestyle ◽  
Safe Strategy ◽  
Lack Of Exercise

Cardiovascular diseases (CVD) are the leading cause of death and disability worldwide. The main reason for increase of CVD is considered to be unhealthy lifestyle consistent of high fat, refined diet, psychosocial stress, lack of exercise and tobacco. In spite of several recent advances in the management of CVD the incidence is rapidly increasing specially in the developing countries and their economic burden is huge. There is a need for new cost effective and safe strategy to control this growing epidemic of CVD. Yoga may be such an alternative for controlling CVD. Several research studies suggest that yoga may be promising technique for primary and secondary prevention of CVD and these will be reviewed briefly in this chapter.

scholarly journals Seasonal Variations of Heart Failure and Acute Coronary Syndrome in a Referral Center of Heart Diseases in Ahvaz, Southwest of Iran

2021 ◽  
Vol In Press (In Press) ◽  
Author(s):  
Farzaneh Ahmadi ◽  
Parisa Pourkhosravi
Keyword(s):  
Myocardial Infarction ◽  
Heart Failure ◽  
Acute Coronary Syndrome ◽  
Heart Disease ◽  
Seasonal Variations ◽  
Heart Diseases ◽  
Cold Season ◽  
Coronary Syndrome ◽  
Number Of Patients

Background: Despite the role of hot weather and activity at high temperatures in physical and environmental stress influencing the occurrence or recurrence of heart disease, the role of seasonal variations in temperature in this disease has not been well studied. Objectives: This study aimed to investigate the relation of seasonal variations in temperature to the number of patients with ischemic heart disease and heart failure (HF). Methods: We extracted data, including file number, diagnosis, age, gender, hospitalization date, and discharge date, from the medical files of patients admitted to a referral center of heart diseases in a tropical region from 2013 to 2015. Results: Diagnosed and studied patients (n = 4,041) were as follows: 625 (patients with HF), 2410 (patients with unstable angina), and 1006 (patients with myocardial infarction). A total of 57% of patients were male, and 43% were female. The average number of patients per day (P/d) in the cold season was higher than in other seasons (5.89 versus 5.53 in the moderate season and 5.18 during the warm season). The mean length of hospitalization for patients with myocardial infarction (MI) and HF in the cold season was longer than in other seasons, and this difference was statistically significant (P = 0.035 and 0.021, respectively). Conclusions: All hospitalizations occurring with these diagnoses in cold seasons are longer, increasing the burden on the health care system. There are considerable seasonal variations in HF hospitalization and mortality. Immunization against pneumococcus and influenza and also more care are recommended in HF patients. There is a need for a season-based approach for better handling of acute coronary syndrome (ACS).

Psychophysiological Rationale for Use of Yoga in Heart Disease

2019 ◽  
pp. 477-491
Author(s):  
Subhash Manchanda ◽  
Kushal Madan
Keyword(s):  
Developing Countries ◽  
Heart Disease ◽  
Cardiovascular Diseases ◽  
Secondary Prevention ◽  
Cause Of Death ◽  
Economic Burden ◽  
Cost Effective ◽  
Unhealthy Lifestyle ◽  
Safe Strategy ◽  
Lack Of Exercise

Cardiovascular diseases (CVD) are the leading cause of death and disability worldwide. The main reason for increase of CVD is considered to be unhealthy lifestyle consistent of high fat, refined diet, psychosocial stress, lack of exercise and tobacco. In spite of several recent advances in the management of CVD the incidence is rapidly increasing specially in the developing countries and their economic burden is huge. There is a need for new cost effective and safe strategy to control this growing epidemic of CVD. Yoga may be such an alternative for controlling CVD. Several research studies suggest that yoga may be promising technique for primary and secondary prevention of CVD and these will be reviewed briefly in this chapter.

scholarly journals Prevalences and healthcare expenditures related to 58 health conditions from 2012 to 2017 in France: diseases and healthcare expenditure mapping, a national population-based study

2020 ◽  
Author(s):  
Antoine Rachas ◽  
Christelle Gastaldi-Menager ◽  
Pierre Denis ◽  
Thomas Lesuffleur ◽  
Muriel Nicolas ◽  
...  
Keyword(s):  
Public Health ◽  
Mental Illness ◽  
National Health ◽  
Psychotic Disorders ◽  
Healthcare Expenditure ◽  
General Scheme ◽  
Health Conditions ◽  
Health Priorities ◽  
Total Expenditure ◽  
Number Of Patients

Background Description of the prevalence of diseases and resources mobilized for the management of each disease is essential to identify public health priorities. We described the prevalences of 58 health conditions and all reimbursed healthcare expenditure by health condition in France between 2012 and 2017. Methods and Findings All national health insurance general scheme beneficiaries (87% of the French population) with at least one reimbursed healthcare expenditure were included from the French national health database. We identified health conditions (diseases, episodes of care, chronic treatments) by algorithms using ICD-10 codes for long-term diseases or hospitalisations, medications or medical procedures. We reported crude and age and sex-standardized annual prevalences between 2012 and 2017, and total and mean (per patient) reimbursed expenditure attributed to each condition without double counting, and according to the type of expenditure. In 2017, in a population of 57.6 million people (54% of women, median age: 40 years), the most prevalent diseases were diabetes (standardized prevalence: 5.8%), chronic respiratory diseases (5.5%) and chronic coronary heart disease (2.9%). Diseases concentrating the highest expenditures were active cancers (10% of total expenditure of 140.1 billion euros), mental illness (10%; neurotic and mood disorders: 4%; psychotic disorders: 3%), and chronic cardiovascular diseases (8%). Between 2012 and 2017, the most marked increase in total expenditure concerned liver and pancreatic diseases (+9.3%), related to the increased drug expenditure in 2014. Conversely, the increase in the number of patients (and the prevalence) explained the majority of the increase of total expenditures for cardiovascular disease, diabetes and mental illness. Conclusions These results showed a regular increase of the prevalence and expenditure of certain chronic diseases, probably related to ageing of the population, and increased expenditures related to major therapeutic innovations. The Diseases and Healthcare Expenditure Mapping therefore enlightens decision-makers in charge of public health and health accounts.

scholarly journals Lifelong approach to prevention and control of cardiovascular diseases – a road from theory to practice in the Federation of Bosnia and Herzegovina

2018 ◽  
Vol 8 (1) ◽  
pp. 1-9
Author(s):  
Senka Mesihovic-Dinarevic ◽  
Aida Ramić-Čatak ◽  
Zaim Jatic
Keyword(s):  
Cardiovascular Diseases ◽  
Cause Of Death ◽  
Bosnia And Herzegovina ◽  
Prevention And Control ◽  
Health Sector ◽  
Steady Increase ◽  
Cross Sectional ◽  
Coronary Syndrome ◽  
Cvd Prevention ◽  
And Control

Cardiovascular diseases (CVDs) are the major cause of disability and premature death all over the world. Annually, 17.5 million people die from CVDs, representing 30% of the total number of deaths. Despite established guidelines for the treatment of acute coronary syndrome, cardiac weakness, atrial fibrillation and CVD prevention, many patients remain inadequately treated, particularly in less developed nations. A brief overview of the development of CVDs, description of the current practice guidelines, and a cross sectional analyses of the status of CVD prevention and control in the Federation of Bosnia and Herzegovina is given. In the past 7 years, there has been a steady increase in deaths, where half of all deaths in the Federation of Bosnia and Herzegovina are attributed to CVDs. Deaths from the acute myocardial infarction had a rate of 91.0/100,000 inhabitants, a significant increase compared to 2010, when this rate was 69.2. The second leading cause of death, a stroke, with a rate of 87.1 showed a slight decrease compared to 2010, when it was 89.9. The third leading cause of death, heart failure, with a rate of 68.4, has a slight decrease compared to 2010, when the rate was 75.7. CVDs are the leading cause of mortality in Federation of Bosnia and Herzegovina, which, in addition to the large number of premature deaths, also causes major costs for the health sector and economy.

Sign in / Sign up

Export Citation Format

Share Document